Lemoli, Roberto M.

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

DiNardo, C. D., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Wei, A. H., Konopleva, M., Döhner, H., Letai, A., Fenaux, P., et al. (2020) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 2,900

The P2X7 Receptor: A Key Player in IL-1 Processing and Release

Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology

Adenosine and Purinergic SignalingInflammasome and immune disorders

Cited by 1,025

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications

Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters

T-cell and B-cell ImmunologyImmunotherapy and Immune Responses

Cited by 147

Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status

Cea, M., Cagnetta, A., Acharya, C., Acharya, P., Tai, Y.-T., Yang, C., Lovera, D., Soncini, D., Miglino, M., Fraternali-Orcioni, G., et al. (2016) · Clinical Cancer Research

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 28

Gpr171, a putative P2Y-like receptor, negatively regulates myeloid differentiation in murine hematopoietic progenitors

Rossi, L., Lemoli, R. M., & Goodell, M. A. (2013) · Experimental Hematology

Adenosine and Purinergic SignalingHematopoietic Stem Cell Transplantation

Cited by 20

Measurable Residual Disease in High-Risk Acute Myeloid Leukemia

Cluzeau, T., Lemoli, R. M., McCloskey, J., & Cooper, T. (2022) · Cancers

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 13